But the exact molecular pathway accounting for the interaction between VEGF and Del1 in tumor cells needs further investigation, which might improve our understanding of the role of Del1 in tumor angiogenesis, and optimize Del1-targeted cancer therapy. This evidence concerns the gene VEGFA and neoplasm.